Existing investors Johnson & Johnson and WuXi AppTec have returned to take part in the neurological drug developer’s latest funding.

UCSF spinout Siolta Therapeutics picked up SymBiosis and Kirin Holdings in a round set to fund efficacy trials of its potential asthma treatment.

Siolta Therapeutics picked up SymBiosis and Kirin Holdings in a round set to fund efficacy trials of its potential asthma treatment.

Willow, which markets discreet breastfeeding pump technology, reportedly counts Johnson & Johnson Innovation – JJDC as an investor.

Pureos Bioventures has backed five spinouts so far from its multi-corporate-backed, biotech-focused fund.

Pureos Bioventures has backed five spinouts so far from its inaugural biotech-focused fund, which has reached its final close.

HBM Healthcare chipped in additional funding to bring University of Basel spinout Polyneuron's series A round to $39.7m.

Backed by Shanghai Fudan University previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.

Backed by Sinopharm Capital previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.

TriNetX had raised $102m in funding from investors including Merck & Co, Mitsui and Itochu before agreeing to a purchase by Carlyle.